Registered entities
Lineage Cell Therapeutics, Inc.
Reg. No. 876343United States
Biotime, Inc.
Reg. No. 943127919United States
Innovation
23 patent families (10 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 1,638 times.
| Year | Filings |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 9 |
| 2022 | 6 |
| 2023 | 12 |
| 2024 | 11 |
| 2025 | 7 |
| 2026 | 1 |
Social engagement
Social engagement: 7K social following, 9 posts in the last 12 months — below the industry typical range.
Investor mix
6 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 6 | 100% |
Recent activity
15 Jun 2026
Event
From Innovation to Approval: Bringing Novel Treatments to Market
10 Jun 2026
Event
From Innovation to Approval: Bringing Novel Treatments to Market
28 May 2026
Event
BioConnect Investor Conference